
Evonik invests in Pangaea Ventures fund
CVC-backed German speciality chemicals maker Evonik has invested in Pangaea Ventures Fund III through its recently established venture unit.
The company, which last month cancelled a planned IPO, invested in the Vancouver-based fund as part of Evonik Corporate Venturing's internationalisation strategy.
The company's venture arm was founded as part of the Innovation Management unit in January 2012 and plans to invest up to €100m over the medium term in start-ups and specialist venture funds in Europe, the US and Asia.
Pangaea Ventures invests in early-stage cleantech companies with a focus on speciality chemicals – an area of expertise for Evonik.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater